CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
China National Accord Medicines Corporation Limited Company Snapshot
China National Accord Medicines Corporation Limited operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares China National Accord Medicines Corporation Limited with three other companies in this sector in China: Yunnan Baiyao Group Co., Ltd. (2015 sales of 20.74 billion Chinese Renmimbi [US$3.01 billion] of which 56% was Comodities Trading), Huadong Medicine Company Limited (21.73 billion Chinese Renmimbi [US$3.15 billion] of which 80% was Commerce), and China Medicine Health Industry Co Ltd (20.56 billion Chinese Renmimbi [US$2.99 billion] of which 48% was Pharmaceutical Business-pure/simple vend).

Sales Analysis. During the year ended December of 2015, sales at China National Accord Medicines Corporation Limited were 25.99 billion Chinese Renmimbi (US$3.77 billion). This is an increase of 8.5% versus 2014, when the company's sales were 23.95 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at China National Accord Medicines Corporation Limited (and since 2010, sales have increased a total of 99%). Sales of Rental Revenue saw an increase that was more than double the company's growth rate: sales were up 814.2% in 2015, from 11.41 million Chinese Renmimbi to 104.31 million Chinese Renmimbi. Not all segments of China National Accord Medicines Corporation Limited experienced an increase in sales in 2015: sales of Logistics and Warehousing Services fell 8.2% to 29.49 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). China National Accord Medicines Corporation Limited also experienced decreases in sales in Pharmaceutical Manufacturing (down 0.8% to 1.63 billion Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
China National Accord Medicines Corporation Limited
  Stock Performance Chart for China National Accord Medicines Corporation Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 40.03
(Figures in Chinese Renmimbi)
1 Week -0.1%   13 Weeks 3.2%  
4 Weeks -6.9%   52 Weeks n/a  
 
China National Accord Medicines Corporation Limited Key Data:
  Ticker: 200028 Country: China
  Exchanges: SZN Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2015 Sales 25,986,839,871
(Year Ending Jan 2016).
Employees: 4,310
  Currency: Chinese Renmimbi Market Cap: 14,517,846,543
  Fiscal Yr Ends: December Shares Outstanding: 362,631,943
  Share Type: B Gu Closely Held Shares: 192,496,781
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.